Human medicinal products
SPC PL
Veterinary medicinal
products
SPC PL
Herbal medicinal products
SPC PL
Name of the medicinal
product
A B C D E F G
H I J K L M N
O P Q R S T U
V W X Y Z Å Ä Ö
Name of the medicinal
product

Marketing authorisation
holder

Marketing authorisation
number

ATC Code Codes

Free text search

Active agent

Pharmaceutical form

Adverse effect

Therapeutic indication

Contraindication

Insert text in the fields in Finnish


Summaries of Product Characteristics (SPC) for Human medicinal products

The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.

Search with the first character of the name of the medicinal product: d


Summaries of Product Characteristics 1 - 30 of 334
  1  2  3  4  5  6  7  8  9  10  11  12  |  Next 30   >    
Package
leaflet
Status for
supply
Name of the medicinal product

PL

Resepti/itsehoito

D-Calsor 500 mg-10 mikrog (400 IU), 500 mg-20 mikrog(800IU) tabletti, kalvopäällysteinen SPC 2020-10-29

European Medicines Agency's website:
Dabigatran etexilate Accord - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Dabigatran etexilate Glenmark 110 mg kapseli, kova SPC 2024-03-07

PL

Resepti

Dabigatran etexilate Glenmark 150 mg kapseli, kova SPC 2024-03-07

PL

Resepti

Dabigatran etexilate Glenmark 75 mg kapseli, kova SPC 2024-02-26

PL

Resepti

Dabigatran etexilate Krka 110 mg kapseli, kova SPC 2023-10-20.docx

PL

Resepti

Dabigatran etexilate Krka 150 mg kapseli, kova SPC 2023-10-20.docx

PL

Resepti

Dabigatran etexilate Krka 75 mg kapseli, kova SPC 2023-10-20.docx

PL

Resepti

Dabigatran etexilate Orion 110 mg kapseli, kova SPC 2024-06-10.docx

PL

Resepti

Dabigatran etexilate Orion 150 mg kapseli, kova SPC 2024-06-10.docx

PL

Resepti

Dabigatran etexilate Orion 75 mg kapseli, kova SPC 2024-06-10.docx

PL

Resepti

Dabigatran etexilate Sandoz 110 mg kapseli, kova SPC 2024-10-25

PL

Resepti

Dabigatran etexilate Sandoz 150 mg kapseli, kova SPC 2024-10-25

PL

Resepti

Dabigatran etexilate Sandoz 75 mg kapseli, kova SPC 2024-10-25

PL

Resepti

Dabigatran etexilate STADA 110 mg kapseli, kova SPC 2023-11-09

PL

Resepti

Dabigatran etexilate STADA 150 mg kapseli, kova SPC 2023-11-09

PL

Resepti

Dabigatran etexilate STADA 75 mg kapseli, kova SPC 2023-11-09

PL

Resepti

Dabigatran etexilate STADA Nordic 110 mg kapseli, kova SPC 2024-01-16

PL

Resepti

Dabigatran etexilate STADA Nordic 150 mg kapseli, kova SPC 2024-01-16

PL

Resepti

Dabigatran etexilate STADA Nordic 75 mg kapseli, kova SPC 2024-01-16

European Medicines Agency's website:
Dabigatran etexilate Teva (ent. Dabigatran etexilate Leon Farma) - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Dabigatran etexilate Viatris 110 mg kapseli, kova SPC 2024-01-30

PL

Resepti

Dabigatran etexilate Viatris 150 mg kapseli, kova SPC 2024-01-30

PL

Resepti

Dabigatran etexilate Viatris 75 mg kapseli, kova SPC 2024-01-30

PL

Resepti

Dacarbazine Lipomed 200 mg injektio-infuusiokuiva-aine-liuosta varten SPC 2024-04-10

PL

Resepti

Dacarbazine Lipomed 500 mg, 1000 mg infuusiokuiva-aine, liuosta varten SPC 2024-04-10

PL

Resepti

Dacarbazine medac 100 mg, 200 mg, 500 mg, 1000 mg injektio-infuusiokuiva-aine liuosta varten SPC 2023-08-31

PL

Resepti

Dacarbazine medac 100 mg, 200 mg, 500 mg, 1000 mg injektio-infuusiokuiva-aine liuosta varten SPC 2023-08-31

PL

Resepti

Dacepton 10 mg-ml injektioneste SPC 2023-09-29

PL

Resepti

Dacepton 5 mg-ml infuusioneste SPC 2023-09-29

  1  2  3  4  5  6  7  8  9  10  11  12  |  Next 30   >